Every material Form 8-K MARCHEX INC has filed with the SEC since May 13, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Marchex reported second-quarter 2026 revenue of $11.0 million, down from $11.7 million a year earlier, and a net loss of $0.4 million, or $(0.01) per diluted share, compared with net income of $0.1 million a year earlier. Adjusted EBITDA rose to $0.7 million from $0.6 million, but the Archenia acquisition, which closed July 1, 2026, is not included in these reported results, and the company gave a third-quarter pro forma combined revenue outlook of $16.0 million to $16.5 million.
Q2 2026 revenue was $11.0 million, compared with $11.7 million in Q2 2025.
Q2 2026 net loss was $0.4 million, or $(0.01) per diluted share, versus net income of $0.1 million, or $0.00 per share, a year earlier.
Adjusted EBITDA was $0.7 million, including $1.0 million of reorganization and acquisition-related costs; adjusted non-GAAP income per share was $0.00 versus $0.02.
Third-quarter 2026 pro forma combined outlook: revenue of $16.0 million to $16.5 million and adjusted EBITDA, net of reorganization and acquisition costs, of $2.3 million to $2.5 million.
Marchex completed its acquisition of 100% of Archenia, Inc., a performance-based marketing technology company, on July 1, 2026. Stockholders approved the deal at a special meeting on the same day, with about 99.9% approval under both the simple majority and majority-of-the-minority votes. The company issued $10 million in 6% convertible notes to the sellers, and may issue additional shares if Archenia meets revenue, Adjusted EBITDA and integration targets.
Acquisition closed July 1, 2026; Archenia is a performance-based marketing technology company.
Company issued $10 million of convertible promissory notes bearing 6% interest, payable in three equal tranches at 12, 18 and 24 months after closing.
Notes convert into Class B common stock at $1.80 per share.
Earn-out of 2 million Class B shares for each of the first two 12-month periods, subject to revenue or Adjusted EBITDA growth and integration or customer retention targets.
Marchex reported first-quarter 2026 revenue of $10.6 million, down from $11.4 million a year earlier, while its net loss narrowed to $1.7 million from $2.0 million. The company raised its second-quarter 2026 Adjusted EBITDA guidance to $1.6 million to $1.8 million, up from prior guidance of more than $1 million, and said the proposed Archenia acquisition is expected to close in July 2026 if stockholders approve it.
Q1 2026 revenue was $10.6 million versus $11.4 million in Q1 2025.
Net loss was $1.7 million, or $(0.04) per diluted share, versus $2.0 million, or $(0.05), a year earlier.
Q2 2026 Adjusted EBITDA is now expected to be $1.6 million to $1.8 million, up from prior guidance of more than $1 million.
Marchex signed a Stock Purchase Agreement on May 8, 2026 to acquire 100% of Archenia, Inc.; closing is expected in July 2026, subject to majority approval by disinterested stockholders.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every MARCHEX INC filing is on SEC EDGAR ↗. 8-K briefs of other companies →